LCTX

#2830
Lineage Cell Therapeutics, Inc. Common Stock
1.3 4 USD
+9900.00%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
1.34
1.35
년간 변동
0.01
1.98
일일 변동
+9900.00%
월간 변동
-10.65%
6달 변화
-21.96%
년간 변동율
-21.96%
이전 종가
0.0 1
Open
1.3 5
저가
1.3 4
High
1.3 5
양
19
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 334.06 M
  • Employee 77
  • Founded 1990
  • CEO N/A
  • Website www.lineagecell.com
  • Headquarter California, United States
  • FIGI BBG000G8RJY6
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-5.96
주가매출액비율
26.4

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer.

뉴스